← Leaderboards
Etienne L Sibille
Columbia University Health Sciences
$9,577,912
Attributed
$10,171,028
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$10,171,028 · 11
By mechanism
R01$5,867,025 · 2
P50$1,637,778 · 3
R21$1,198,110 · 3
K01$792,502 · 1
K02$589,275 · 1
F32$86,338 · 1
Top collaborators
- Colleen A Mcclung2 shared
- George C. Tseng2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mate Istvan Milak$3,167,953
- Stephanie Ann Cosentino$10,754,052
- Sarah H Lisanby$7,610,671
- Joseph Hyungwoo Lee$11,176,176
- Tarique Dhyan Perera$2,843,869
Others in their field
Top investigators on “Autopsy”
- Paul S. Aisen · Cognition Therapeutics, Inc.$90,134,611
- David A Bennett · Rush University Medical Center$80,676,079
- Reisa A. Sperling · Banner Health$74,324,940
- Bradley F Boeve · Mayo Clinic Rochester$59,286,925
- Richard Mayeux · Columbia University Health Sciences$52,493,915
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$51,543,301
Research focus
AutopsyGenesBiologicalFutureMolecularBaseCohortAffectTranscriptGene ExpressionSamplingMolecular ProfilingBrainMolecular PathologyBrain RegionFunctional DisorderSpecificityNeuronsPatternPathologyIn Situ HybridizationPathway InteractionsMajor Depressive DisorderAntidepressive Agents
Grant awards (42)
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$336,380
P50 · FY2018 · MH · contact PI
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$325,548
P50 · FY2017 · MH · contact PI
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$325,547
P50 · FY2016 · MH · contact PI
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$1
P50 · FY2016 · MH · contact PI
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$1
P50 · FY2016 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$423,696
R01 · FY2015 · MH · contact PI
Corticolimbic Somatostatin-Related Inhibitory Dysfunction in Major Depression$407,757
R01 · FY2015 · MH
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$325,547
P50 · FY2015 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$172,007
R01 · FY2015 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$507,725
R01 · FY2014 · MH · contact PI
Corticolimbic Somatostatin-Related Inhibitory Dysfunction in Major Depression$407,854
R01 · FY2014 · MH
Molecular Alterations of Cortical Layer 3 Pyramidal Cells in Schizophrenia$324,754
P50 · FY2014 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$476,098
R01 · FY2013 · MH · contact PI
Corticolimbic Somatostatin-Related Inhibitory Dysfunction in Major Depression$391,631
R01 · FY2013 · MH · contact PI
Integrative Analysis of Transcriptome, Genome and Disease Diversity in MDD$199,646
R21 · FY2013 · MH
Molecular characterization of a corticolimbic network in depression$117,855
K02 · FY2013 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$84,880
R01 · FY2013 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$477,344
R01 · FY2012 · MH · contact PI
Corticolimbic Somatostatin-Related Inhibitory Dysfunction in Major Depression$349,829
R01 · FY2012 · MH · contact PI
Peripheral Biomarkers in Major Depression$224,327
R21 · FY2012 · MH · contact PI
Integrative analysis of transcriptome, genome and disease diversity in major depr$170,975
R21 · FY2012 · MH
Molecular characterization of a corticolimbic network in depression$117,855
K02 · FY2012 · MH · contact PI
Molecular Aging of the Human Brain: Genetic Modulation and Functional Outcomes$483,157
R01 · FY2011 · MH · contact PI
Corticolimbic Somatostatin-Related Inhibitory Dysfunction in Major Depression$357,688
R01 · FY2011 · MH · contact PI
Peripheral Biomarkers in Major Depression$186,537
R21 · FY2011 · MH · contact PI
Molecular characterization of a corticolimbic network in depression$117,855
K02 · FY2011 · MH · contact PI
Transcriptome analysis in major depression$331,737
R01 · FY2010 · MH · contact PI
Modeling Core Behavioral, Neuroendocrine and Molecular Features of Depression$189,375
R21 · FY2010 · MH · contact PI
Molecular characterization of a corticolimbic network in depression$117,855
K02 · FY2010 · MH · contact PI
Transcriptome analysis in major depression$331,807
R01 · FY2009 · MH · contact PI
Modeling Core Behavioral, Neuroendocrine and Molecular Features of Depression$227,250
R21 · FY2009 · MH · contact PI
Molecular characterization of a corticolimbic network in depression$117,855
K02 · FY2009 · MH · contact PI
Transcriptome analysis in major depression$331,875
R01 · FY2008 · MH · contact PI
Transcriptome analysis in major depression$331,940
R01 · FY2007 · MH · contact PI
Genomic Characterization in Depression and Suicide.$161,002
K01 · FY2007 · MH · contact PI
Genomic Characterization in Depression and Suicide.$159,746
K01 · FY2006 · MH · contact PI
Genomic Characterization in Depression and Suicide.$158,668
K01 · FY2005 · MH
Genomic Characterization in Depression and Suicide.$123,163
K01 · FY2004 · MH
Genomic Characterization in Depression and Suicide.$34,035
K01 · FY2004 · MH
Genomic Characterization in Depression and Suicide.$155,888
K01 · FY2003 · MH
Altered Gene Expression in Antidepressant Treatment$46,142
F32 · FY2002 · MH
Altered Gene Expression in Antidepressant Treatment$40,196
F32 · FY2001 · MH